Skip to content

Cannabis app trial found less use, without clear changes in disorder severity

A culturally tailored mobile program for Black adults with probable cannabis use disorder showed promising use-related results, while several other outcomes did not improve significantly.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

The intervention group showed lower cannabis-use frequency and less time intoxicated than the assessment-only group. However, cannabis-related problems and disorder severity did not show significant improvement at follow-up. This small preliminary trial suggests changes in some use patterns, while leaving broader clinical benefit and longer-term effects unresolved.

Keep in mind

The trial was preliminary, and the abstract does not provide effect sizes or confidence intervals. The authors call for larger trials; persistence of any benefit beyond the study period remains unclear.

THE RESULT, WITH CONTEXT

What researchers found

Lower values, statistically significant

Cannabis-use frequency and time intoxicated

Mobile intervention plus assessments versus assessments alone during the 6-week trial; effect sizes were not reported.

Behav Res Ther, 2025 · Original source ↓

What both groups received

Both groups completed repeated assessments in daily life. Only the intervention group also received the culturally tailored mobile program, which combined skills addressing cannabis use with skills targeting behaviors described as false safety behaviors.

Engagement and clinical outcomes differ

The authors described the program as feasible and acceptable, with high engagement. Those implementation findings are distinct from clinical outcomes: cannabis-related problems, disorder severity, and false safety behavior use showed no significant intervention effects.

CHECK THE ORIGINAL

The original publication

Mobile intervention to address cannabis use disorder among black adults: A proof-of-concept randomized controlled trial.

Garey L, Jones AA, Nizio P et al.
Behav Res Ther · 2025

PubMed ID
41109077
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.